![Lupin Pharma Canada announces the availability of Intrarosa® (prasterone vaginal ovules), a new treatment option in Canada for women with postmenopausal vulvovaginal atrophy Lupin Pharma Canada announces the availability of Intrarosa® (prasterone vaginal ovules), a new treatment option in Canada for women with postmenopausal vulvovaginal atrophy](https://mma.prnewswire.com/media/1989512/Lupin_Pharma_Canada_Lupin_Pharma_Canada_announces_the_availabili.jpg?p=facebook)
Lupin Pharma Canada announces the availability of Intrarosa® (prasterone vaginal ovules), a new treatment option in Canada for women with postmenopausal vulvovaginal atrophy
![AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosa (Prasterone) | World Pharma Today AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosa (Prasterone) | World Pharma Today](https://www.worldpharmatoday.com/wp-content/uploads/2017/02/images_article_production_a_manfact_amag_endoceutics_pharma.jpg)
AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosa (Prasterone) | World Pharma Today
![These highlights do not include all the information needed to use INTRAROSA® safely and effectively. See full prescribing information for INTRAROSA®. INTRAROSA® (prasterone) vaginal inserts Initial U.S. Approval: 2016 These highlights do not include all the information needed to use INTRAROSA® safely and effectively. See full prescribing information for INTRAROSA®. INTRAROSA® (prasterone) vaginal inserts Initial U.S. Approval: 2016](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=intrarosa-13.jpg&id=520481)
These highlights do not include all the information needed to use INTRAROSA® safely and effectively. See full prescribing information for INTRAROSA®. INTRAROSA® (prasterone) vaginal inserts Initial U.S. Approval: 2016
![These highlights do not include all the information needed to use INTRAROSA ® safely and effectively. See full prescribing information for INTRAROSA ®. INTRAROSA ® (prasterone) vaginal inserts Initial U.S. Approval: 2016 These highlights do not include all the information needed to use INTRAROSA ® safely and effectively. See full prescribing information for INTRAROSA ®. INTRAROSA ® (prasterone) vaginal inserts Initial U.S. Approval: 2016](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=401-28+image.jpg&id=687832)